Immunocore Holdings plc (IMCR) KPIs and segments
Close on Nov 17, 2026Market cap $1.43BP/E –Yield 0.00%
KPIs & segments
Operating metrics and segments that drive Immunocore's business
Immunocore's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue from sale of therapies, net($M)3 | 116 | 107 | 104 | 104 | 98.0 | 93.9 | 84.1 | 80.2 | 75.3 | 70.3 | |||
United States($M) | 74.9 | 67.4 | 69.0 | 67.3 | 64.1 | 56.6 | 63.8 | 57.3 | 55.6 | 50.0 | |||
Europe($M) | 34.1 | 34.4 | 32.1 | 33.5 | 33.0 | 32.8 | 17.8 | 21.1 | 15.4 | 19.0 | |||
International($M) | 6.87 | 4.83 | 3.42 | 2.87 | 0.84 | 4.47 | 2.50 | 1.88 | 4.34 | 1.36 | |||
Collaboration revenue($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.16 | 2.57 | 2.22 | |||
Earlier reporting (last reported 2024)1 | |||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?